和田维药 (837527.OC)

+ 收藏

利润表(和田维药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、营业总收入(元) 241,325,336.08129,621,074.34173,399,935.3085,441,666.07
 营业收入(元) 241,325,336.08129,621,074.34173,399,935.3085,441,666.07
二、营业总成本(元) 180,607,177.9594,093,896.39125,566,074.2361,812,309.69
 营业成本(元) 86,494,482.8344,746,294.5161,713,257.9028,980,365.91
 研发费用(元) 8,244,813.763,558,608.684,323,200.282,119,126.49
 营业税金及附加(元) 2,766,037.791,732,626.961,816,511.61715,616.07
 销售费用(元) 73,468,762.9539,737,873.4251,364,342.6926,643,509.02
 管理费用(元) 9,754,245.754,465,181.136,368,404.793,367,905.07
 财务费用(元) -121,165.13-146,688.31-19,643.04-14,212.87
  其中:利息费用(元) 5,342.803,190.456,055.192,986.81
  其中:利息收入(元) 136,710.50167,714.6531,440.9421,138.12
三、其他经营收益
 加:公允价值变动收益(元) 290,793.98-249,847.93196,859.08
 加:投资收益(元) 849,340.42346,796.10489,421.23-
 资产处置收益(元) 354.87---
 资产减值损失(元) -14,889.42--586,157.41-
 信用减值损失(元) 63,891.03-172,465.3772,522.72168,427.72
 其他收益(元) 386,409.73307,935.511,721,434.74548,738.36
四、营业利润(元) 62,294,058.7436,009,444.1949,780,930.2824,543,381.54
 加:营业外收入(元) 510,561.14510,553.14869,876.0318,771.26
 减:营业外支出(元) 256,831.445,047.04596,800.75-
五、利润总额(元) 62,547,788.4436,514,950.2950,054,005.5624,562,152.80
 减:所得税费用(元) 8,121,520.934,861,251.686,679,808.133,591,570.21
六、净利润(元) 54,426,267.5131,653,698.6143,374,197.4320,970,582.59
(一)按经营持续性分类
  持续经营净利润(元) 54,426,267.5131,653,698.6143,374,197.4320,970,582.59
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 54,426,267.5131,653,698.6143,374,197.4320,970,582.59
 扣除非经常性损益后的净利润(元) 52,570,113.8130,654,627.5540,865,238.1920,297,591.16
七、每股收益
 一、基本每股收益(元) 2.091.211.660.80
 二、稀释每股收益(元) 2.091.211.660.80
九、综合收益总额(元) 54,426,267.5131,653,698.6143,374,197.43-
 归属于母公司所有者的综合收益总额(元) 54,426,267.5131,653,698.6143,374,197.4320,970,582.59
公告日期 2024-04-032023-08-302023-04-262022-08-24
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院